The randomized ACCESS-TAVI study led by PD Dr. Tobias Rheude and DZHK-Prof. Michael Joner from the German Heart Center Munich ...

Ahead of schedule and budget” was the catchphrase for the ribbon-cutting ceremony at Werfen’s opening of their new expanded Innovation Center at their Technology Center for Hemostasis and Acute Care ...

Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V., ...

Thyroid Papillary Carcinoma, Transoral Vestibular Approach, Thyroidectomy, Drainage, Enhanced Recovery after Surgery ...